Ujike, T.
54  results:
Search for persons X
?
2

Identification of CCR8 as a specific marker of tumor tissue..:

Kawashima, A. ; Matsumoto, M. ; Kidani, Y....
European Urology Supplements.  18 (2019)  11 - p. e3557 , 2019
 
?
3

Clinical utility of the mutational landscape and fragment s..:

Uemura, M. ; Yamamoto, Y. ; Fujita, M....
European Urology Supplements.  18 (2019)  1 - p. e160-e161 , 2019
 
?
4

The decline in estimated glomerular filtration rate over th..:

Ujike, T. ; Uemura, M. ; Takezawa, K....
European Urology Supplements.  18 (2019)  1 - p. e1000-e1001 , 2019
 
?
5

Open-label, phase I, dose escalation study to assess safety..:

Fujita, K. ; Nakai, Y. ; Kato, D....
European Urology Supplements.  18 (2019)  1 - p. e1220 , 2019
 
?
6

Fuhrman grade significantly correlated with overall dysfunc..:

Kawashima, A. ; Kanazawa, T. ; Kidani, Y....
European Urology Supplements.  18 (2019)  11 - p. e3540 , 2019
 
?
7

Identification of a novel therapeutic target for castration..:

Yu, I. ; Koh, Y. ; Matsushita, M....
European Urology Supplements.  18 (2019)  1 - p. e1342 , 2019
 
?
8

Extracellular vesicles isolated from human renal cell carci..:

Uemura, M. ; Jingushi, K. ; Nakano, K....
European Urology Supplements.  17 (2018)  2 - p. e112-e113 , 2018
 
?
9

Overexpression of miR-27a-3p is an independent prognostic f..:

Uemura, M. ; Nakata, W. ; Kawashima, A....
European Urology Supplements.  16 (2017)  3 - p. e1704-e1706 , 2017
 
?
10

LOXL2 status correlates with tumor stage and regulates inte..:

Uemura, M. ; Hase, H. ; Kawashima, A....
European Urology Supplements.  16 (2017)  3 - p. e1716 , 2017
 
?
 
?
12

Retrospective analysis of gemcitabine-plus-nedaplatin syste..:

Nagahara, A. ; Kawashima, A. ; Ujike, T....
European Urology Supplements.  15 (2016)  13 - p. e1706-e1707 , 2016
 
?
 
?
14

Serum free testosterone predicts a positive prostate biopsy..:

Ujike, T. ; Nagahara, A. ; Uemura, M....
European Urology Supplements.  15 (2016)  13 - p. e1559-e1560 , 2016
 
1-15